.png)
Do you know that....
Approximately 1 in 40 people are carriers of the genetic mutation that causes SMA, making it one of the most common genetic disorders.
In the MENA region, the lack of standardized referral pathways for Duchenne Muscular Dystrophy (DMD) causes delays in diagnosis and treatment. We aim to build AI-driven software to analyze low MRI muscle tissue scan to provide early detection and comprehensive evaluation of disease management.
Key Features of M^3:
AI Integration - Utilizes Residual U-net and AUTOMAP for enhanced image reconstruction and diagnostic accuracy.
Cost-Effective - Offers affordable low-field MRI imaging, reducing healthcare costs.
Accessible - portable low-field MRI devices for decentralized diagnostics.
Aim and objectives
-
Develop novel, accessible methods for early and accurate diagnosis of musculoskeletal disorders.
-
Create effective therapies to manage disease progression and improve patient outcomes.
-
Design personalized care plans that cater to individual patient needs.
-
Integrate supportive technologies to enhance daily living activities and provide emotional support.
-
Promote education and awareness of genetic conditions and the importance of early diagnosis.
